SD Chell

Prospects in NSAID-derived chemoprevention of colorectal cancer.

D. Hicks, D. Qualtrough, C. Paraskeva, 2005, Biochemical Society transactions.

Inhibition of COX‐2 with NS‐398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy

D. Qualtrough, C. Paraskeva, D. Elder, 2007, Cell proliferation.